What does Dr. David Strybol do?

Dr. David Strybol is a specialist medical practice in Landen. Private Limited, started on 5 January 2018, 1 establishment.

What is the address of Dr. David Strybol?

The registered office of Dr. David Strybol is located at Luikerlaan 18, 3400 Landen.

Is Dr. David Strybol still active?

Yes. According to the CBE (30 October 2026) Dr. David Strybol is active, legal situation “Normale toestand”, started on 5 January 2018.

Is Dr. David Strybol registered on Peppol?

Yes, Dr. David Strybol is registered on the Peppol network with ID 0208:0687585191.

What is the enterprise number of Dr. David Strybol?

The enterprise number of Dr. David Strybol is BE0687585191.

When was Dr. David Strybol founded?

Dr. David Strybol was founded on 5 January 2018.

Who are the directors of Dr. David Strybol?

According to the 2025 annual accounts, the directors of Dr. David Strybol are: David Strybol.

Is Dr. David Strybol a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 January 2018; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. David Strybol make in 2025?

Dr. David Strybol posted a profit after taxes of € 216,865 in financial year 2025.

What is the revenue of Dr. David Strybol?

As a small company, Dr. David Strybol is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 304,701.

Dr. David Strybol (Private Limited) - Landen

Dossier Dr. David Strybol, printed on 30 October 2026 from databakkes.be/en/0687585191/dr-david-strybol. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. David Strybol from Landen, company number BE0687585191, closed financial year 2025 with a result of € 216,865 after tax. For that financial year Dr. David Strybol recorded a gross margin of € 304,701 and equity of € 194,577. Compared with financial year 2024, the result moved from € 160,134 to € 216,865. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 12, 2025.

What it is worth Healthy

€ 194,577

▼ 45% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 216,865

▲ 35% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 52,507

▼ 44% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 376,999 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 29,485

▼ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,131

▼ 57% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 980

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 266,708 Gross margin 2022: € 266,708 First fiscal year in the series	€ 212,544 Gross margin 2023: € 212,544 ▼ 20% vs 2022 (€ 266,708) Unfavourable step	€ 228,982 Gross margin 2024: € 228,982 ▲ 8% vs 2023 (€ 212,544) Favourable step	€ 304,701 Gross margin 2025: € 304,701 ▲ 33% vs 2024 (€ 228,982) Favourable step	▲ 33%
Profit after taxes	€ 189,409 Profit after taxes 2022: € 189,409 First fiscal year in the series	€ 148,361 Profit after taxes 2023: € 148,361 ▼ 22% vs 2022 (€ 189,409) Unfavourable step	€ 160,134 Profit after taxes 2024: € 160,134 ▲ 8% vs 2023 (€ 148,361) Favourable step	€ 216,865 Profit after taxes 2025: € 216,865 ▲ 35% vs 2024 (€ 160,134) Favourable step	▲ 35%
Equity	€ 377,786 Equity 2022: € 377,786 First fiscal year in the series	€ 342,938 Equity 2023: € 342,938 ▼ 9% vs 2022 (€ 377,786) Unfavourable step	€ 354,711 Equity 2024: € 354,711 ▲ 3% vs 2023 (€ 342,938) Favourable step	€ 194,577 Equity 2025: € 194,577 ▼ 45% vs 2024 (€ 354,711) Unfavourable step	▼ 45%
Total debts	€ 26,761 Total debts 2022: € 26,761 First fiscal year in the series	€ 16,779 Total debts 2023: € 16,779 ▼ 37% vs 2022 (€ 26,761) Favourable step	€ 14,993 Total debts 2024: € 14,993 ▼ 11% vs 2023 (€ 16,779) Favourable step	€ 226,077 Total debts 2025: € 226,077 ▲ € 211,084 vs 2024 (€ 14,993) Unfavourable step	▲ € 211,084
Cash	€ 209,933 Cash 2022: € 209,933 First fiscal year in the series	€ 53,061 Cash 2023: € 53,061 ▼ 75% vs 2022 (€ 209,933) Unfavourable step	€ 94,392 Cash 2024: € 94,392 ▲ 78% vs 2023 (€ 53,061) Favourable step	€ 52,507 Cash 2025: € 52,507 ▼ 44% vs 2024 (€ 94,392) Unfavourable step	▼ 44%
Land & buildings	€ 20,517 Land & buildings 2022: € 20,517 First fiscal year in the series	€ 17,612 Land & buildings 2023: € 17,612 ▼ 14% vs 2022 (€ 20,517) Unchanged	€ 20,483 Land & buildings 2024: € 20,483 ▲ 16% vs 2023 (€ 17,612) Unchanged	€ 16,093 Land & buildings 2025: € 16,093 ▼ 21% vs 2024 (€ 20,483) Unchanged	▼ 21%
Retained profit	€ 365,386 Retained profit 2022: € 365,386 First fiscal year in the series	€ 324,338 Retained profit 2023: € 324,338 ▼ 11% vs 2022 (€ 365,386) Unfavourable step	€ 336,111 Retained profit 2024: € 336,111 ▲ 4% vs 2023 (€ 324,338) Favourable step	€ 175,977 Retained profit 2025: € 175,977 ▼ 48% vs 2024 (€ 336,111) Unfavourable step	▼ 48%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 189,409 Dividend 2023: € 189,409 Unchanged (€ 0) Unchanged	€ 148,361 Dividend 2024: € 148,361 ▼ 22% vs 2023 (€ 189,409) Unchanged	€ 376,999 Dividend 2025: € 376,999 ▲ 154% vs 2024 (€ 148,361) Unchanged	▲ 154%
Balance sheet total	€ 404,547 Balance sheet total 2022: € 404,547 First fiscal year in the series	€ 359,717 Balance sheet total 2023: € 359,717 ▼ 11% vs 2022 (€ 404,547) Unchanged	€ 369,703 Balance sheet total 2024: € 369,703 ▲ 3% vs 2023 (€ 359,717) Unchanged	€ 420,654 Balance sheet total 2025: € 420,654 ▲ 14% vs 2024 (€ 369,703) Unchanged	▲ 14%

Key figures of Dr. David Strybol, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Dr. David Strybol?

What happened at Dr. David Strybol in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 12, 2025 New annual accounts for financial year 2025: profit of € 216,865 (▲ 35% vs 2024). Source: NBB ↗
Jan 5, 2018 New establishment in Landen. KBO
Jan 5, 2018 Start of the company according to the CBE. KBO

In short

From € 189,409 profit in 2022 to € 216,865 profit in 2025.

Paid € 216,864 in corporate taxes since 2022.

Best year ever: 2025, with € 216,865 profit.

Paid out € 714,770 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

David Strybol

Dr. David Strybol

Behind Dr. David Strybol is David Strybol.

Directors

According to the 2025 annual accounts

David Strybol

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Luikerlaan 18

3400 Landen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ALEXADENT

€ 115,034 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0687.585.191
VAT number: BE 0687.585.191
Registered office: Luikerlaan 18, 3400 Landen
Names & denominations: Dr. David Strybol
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 January 2018
Peppol: Active · Active since 1 Jan 2001
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗